Strides Pharma Science introduced that its stepdown entirely owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received popularity of Cyclosporine Softgel Capsules USP (Modified), 25 mg, 50 mg, and a hundred mg from america Food & Drug Administration (USFDA).The product is bioequivalent and therapeutically equal to the Reference Listed Drug (RLD), Neoral Capsules 25 mg, 50 mg, and 100 mg, of Novartis Pharmaceuticals Corporation (Novartis). Cyclosporine Softgel Capsules is part of Strides niche product portfolio with restricted opposition in the US marketplace. Strides is the first Indian business enterprise to get popularity of the product. The approval further strengthens Strides immunosuppressant portfolio for the USA markets which now contains of Mycophenolate Mofetil tablets and capsules, Tacrolimus pills and Cyclosporine Softgel Capsules.